Trends in opioid use in commercially insured and Medicare Advantage populations in 2007 16: retrospective cohort study. | AHRQ Patient Safety Network

Trends in opioid use in commercially insured and Medicare Advantage populations in 2007 16: retrospective cohort study. | AHRQ Patient Safety Network

• Study
 
• Published August 2018

Trends in opioid use in commercially insured and Medicare Advantage populations in 2007–16: retrospective cohort study.

Jeffery MM, Hooten WM, Henk HJ, et al. BMJ. 2018;362:k2833.

This retrospective study of claims data found that use of opioid medication among commercially ensured and Medicare populations did not change substantially between 2007 and 2017, despite increasing concerns about risks of opioid use. Opioid prescribing rates were higher and doses were larger among disabled Medicare beneficiaries.

PubMed citationFree full text

Related Resources

JOURNAL ARTICLE › COMMENTARY

Parenteral opioid shortage—treating pain during the opioid-overdose epidemic.

Bruera E. N Engl J Med. 2018;379:601-603.

WEB RESOURCE › MULTI-USE WEBSITE

NAM Action Collaborative on Countering the U.S. Opioid Epidemic.

Washington DC: National Academy of Medicine and the Aspen Institute.

PRESS RELEASE/ANNOUNCEMENT

AHRQ Announces Interest in Health Services Research to Address the Opioids Crisis.

Rockville, MD: Agency for Healthcare Research and Quality. Special Emphasis Notice. August 2, 2018. Publication No. NOT-HS-18-015.

JOURNAL ARTICLE › STUDY

Outpatient opioid prescriptions for children and opioid-related adverse events.

Chung CP, Callahan ST, Cooper WO, et al. Pediatrics. 2018;142:e20172156.

CASES & COMMENTARIES

"The Ultrasound Looked Fine": Point-of-Care Ultrasound and Patient Safety

Resa E. Lewiss, MD

View More